GL1X · GenesisL1 explorer

MolNFT v1 · #103318 · protein

Structural analysis of atovaquone-inhibited cytochrome BC1 complex reveals the molecular basis of antimalarial drug action

4PD4 · Cytochrome B-C1 complex subunit 1, mitochondrial: “Structural analysis of atovaquone-inhibited cytochrome BC1 complex reveals the molecular basis of…”. X-ray diffraction, 7 ligands (3PH, HEM, UMQ), 20 pockets (best druggability…

PDB
4PD4
Type
protein
Length
2,185 residues
Chains
11
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome B-C1 complex subunit 1, mitochondrial; Cytochrome B-C1 complex subunit 2…
EC
1.10.2.2
UniProt
P07256, P07257, P00163, P07143, P08067, P00127, P00128, P08525, P22289
Ligands
3PH, HEM, UMQ, AOQ, 3PE, UQ6, FES
Pockets
20 · best druggability 0.82

Structure

x-ray diffraction · 11 distinct chains · 42% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome B-C1 complex subunit 1, mitochondrialprotein43141% helix, 18% strandP07256
BCytochrome B-C1 complex subunit 2, mitochondrialprotein35239% helix, 18% strandP07257
CCytochrome Bprotein38566% helix, 2% strandP00163
DCytochrome C1, heme protein, mitochondrialprotein24838% helix, 4% strandP07143
ECytochrome B-C1 complex subunit rieske, mitochondrial (EC 1.10.2.2)protein18522% helix, 22% strandP08067
FCytochrome B-C1 complex subunit 6protein7470% helix, 0% strandP00127
GCytochrome B-C1 complex subunit 7protein12665% helix, 0% strandP00128
HCytochrome B-C1 complex subunit 8protein9343% helix, 5% strandP08525
ICytochrome B-C1 complex subunit 9protein5772% helix, 0% strandP22289
JIgh proteinprotein1272% helix, 50% strand—
KIg kappa chain V-V region hp 124E1protein1070% helix, 32% strand—

Ligands and binding sites

  • 3PH · 1,2-diacyl-glycerol-3-sn-phosphate · ligand · 3 copies · chains A, C, E, H, D, I
  • HEM · Protoporphyrin IX containing Fe · ligand · 3 copies · chains C, D
  • UMQ · Undecyl-maltoside · ligand · chains A, E, H, I
  • AOQ · 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione · ligand · chains C
  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine · ligand · chains C
  • UQ6 · 5-(3,7,11,15,19,23-hexamethyl-tetracosa-2,6,10,14,18, 22-hexaenyl)-2,3-dimethoxy-6-methyl-benzene-1,4-diol · ligand · chains C
  • FES · Fe2/s2 (inorganic) cluster · ligand · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16930.820.8666HEM
21660.820.9736empty
33610.790.8943empty
45040.790.8653HEM, UQ6
56730.770.81583PH

Interfaces

25 interfaces between chains.

  • C–G · 1895 Ų buried · 15 hydrogen bonds · protein-protein
  • C–D · 1659 Ų buried · 14 hydrogen bonds · protein-protein
  • A–B · 1577 Ų buried · 18 hydrogen bonds · protein-protein
  • C–H · 1449 Ų buried · 12 hydrogen bonds · protein-protein
  • D–F · 1157 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4PD4 · Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular… · the same entry in another collection · chain K against K, TM-score 1.00
  • P00163 · AlphaFold monomer V2.0 prediction for cytochrome B (P00163) · a predicted model of the same protein · chain C against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.